$KYTX
Kyverna Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Emeryville, CA
KYTX chart
What traders are saying about $KYTX
Latest postsKyverna Therapeutics, Inc. news
- Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 2.2% - Here's Why
MarketBeat ·
- Kyverna Therapeutics, Inc. Estimates – NASDAQ:KYTX
TradingView ·
- H.C. Wainwright Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Maintains Target Price $25
Moomoo ·
- Kyverna Therapeutics highlights updated clinical data with Miv-cel
TipRanks ·
- Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026
Yahoo Finance ·
- A patient with progressive MS had sustained clinical benefit beyond two years after one dose.
Stock Titan ·
- Did Kyverna Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PR Newswire ·
- Kyverna Therapeutics Investor Advances Drug Data IPO Suit (1)
Bloomberg Law News ·
- Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
Yahoo Finance ·
- Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
Yahoo Finance ·
- BioMarin Appoints Cara Bauer as Chief People Officer
Yahoo Finance ·
- KYTX Stock Reverses Gains After One-Year Cell Therapy Trial Data — But CEO Says Disease Burden Justifies A Premium Price
stocktwits.com ·
Kyverna Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$161.3M | -$127.5M | -$60.4M |
| Diluted EPS | $-3.64 | $-3.33 | $-89.61 |
| Total assets (year end) | $293.8M | $304.6M | $75.2M |
| Cash and equivalents (year end) | $124.1M | $96.6M | $34.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kyverna Therapeutics, Inc.
- Ticker
- KYTX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Emeryville, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1994702
- Former names
- Kyverna Therapeutics, Inc.
Frequently asked questions
What exchange is Kyverna Therapeutics, Inc. listed on?
Kyverna Therapeutics, Inc. trades on the Nasdaq under the ticker symbol KYTX.
What industry is Kyverna Therapeutics, Inc. in?
Kyverna Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Kyverna Therapeutics, Inc. headquartered?
Kyverna Therapeutics, Inc.'s business address on file with the SEC is in Emeryville, CA.
When does Kyverna Therapeutics, Inc.'s fiscal year end?
Kyverna Therapeutics, Inc.'s fiscal year ends on December 31.